The X-ray crystal structure of human β-hexosaminidase B provides new insights into Sandhoff disease

被引:100
作者
Maier, T
Strater, N
Schuette, CG
Klingenstein, R
Sandhoff, K
Saenger, W
机构
[1] Free Univ Berlin, Inst Chem Kristallog, D-14195 Berlin, Germany
[2] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany
关键词
hexosaminidase; Sandhoff disease; X-ray crystal structure; sphingolipid metabolism; HEXB;
D O I
10.1016/S0022-2836(03)00311-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human lysosomal beta-hexosaminidases are dimeric enzymes composed of alpha and beta-chains, encoded by the genes HEXA and HEXB. They occur in three isoforms, the homodimeric hexosaminidases B (betabeta) and S (alphaalpha), and the heterodimeric hexosaminidase A (alphabeta), where dimerization is required for catalytic activity. Allelic variations in the HEXA and HEXB genes cause the fatal inborn errors of metabolism Tay-Sachs disease and Sandhoff disease, respectively. Here, we present the crystal structure of a complex of human beta-hexosaminidase B with a transition state analogue inhibitor at 2.3 Angstrom resolution (pdb 1o7a). On the basis of this structure and previous studies on related enzymes, a retaining double-displacement mechanism for glycosyl hydrolysis by beta-hexosaminidase B is proposed. In the dimer structure, which is derived from an analysis of crystal packing, most of the mutations causing late-onset,Sandhoff disease reside near the dimer interface and are proposed to interfere with correct dimer formation. The structure reported here is a valid template also for the dimeric structures of beta-hexosaminidase A and S. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:669 / 681
页数:13
相关论文
共 46 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   MOLECULAR-BASIS OF AN ADULT FORM OF BETA-HEXOSAMINIDASE-B DEFICIENCY WITH MOTOR-NEURON DISEASE [J].
BANERJEE, P ;
SICILIANO, L ;
OLIVERI, D ;
MCCABE, NR ;
BOYERS, MJ ;
HORWITZ, AL ;
LI, SC ;
DAWSON, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (01) :108-115
[3]   MOLECULAR-BASIS OF AN ADULT FORM OF SANDHOFF DISEASE - SUBSTITUTION OF GLUTAMINE FOR ARGININE AT POSITION 505 OF THE BETA-CHAIN OF BETA-HEXOSAMINIDASE RESULTS IN A LABILE ENZYME [J].
BOLHUIS, PA ;
PONNE, NJ ;
BIKKER, H ;
BAAS, F ;
DEJONG, JMBV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1182 (02) :142-146
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   N-ACETYL-BETA-HEXOSAMINIDASE BETA-LOCUS DEFECT AND JUVENILE MOTOR-NEURON DISEASE - A CASE-STUDY [J].
CASHMAN, NR ;
ANTEL, JP ;
HANCOCK, LW ;
DAWSON, G ;
HORWITZ, AL ;
JOHNSON, WG ;
HUTTENLOCHER, PR ;
WOLLMANN, RL .
ANNALS OF NEUROLOGY, 1986, 19 (06) :568-572
[6]   Two mutations remote from an exon/intron junction in the β-hexosaminidase β-subunit gene affect 3′-splice site selection and cause Sandhoff disease [J].
Fujimaru, M ;
Tanaka, A ;
Choeh, K ;
Wakamatsu, N ;
Sakuraba, H ;
Isshiki, G .
HUMAN GENETICS, 1998, 103 (04) :462-469
[7]  
GOMEZLIRA M, 1995, HUM GENET, V96, P417
[8]  
GRAVEL A, 2001, METABOLIC MOL BASES, V3, P3827
[9]   Physiological substrates for human lysosomal β-hexosaminidase S [J].
Hepbildikler, ST ;
Sandhoff, R ;
Kölzer, M ;
Proia, RL ;
Sandhoff, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) :2562-2572
[10]   A Pro504→Ser substitution in the β-subunit of β-hexosaminidase a inhibits α-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease [J].
Hou, YM ;
McInnes, B ;
Hinek, A ;
Karpati, G ;
Mahuran, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :21386-21392